Use of Jumping Mechanography as a Method to Assess Musculoskeletal Status in Older Adults

Muscle Weakness Clinical Trial

Official title:

Use of Jumping Mechanography as a Method to Assess Musculoskeletal Status in Older Adults: A Pilot Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00596089
• Other study ID #: 2007-0274
• Status: Completed
• Phase: N/A
• First received: January 7, 2008
• Last updated: October 1, 2015
• Start date: October 2007
• Est. completion date: March 2008

Study information

• Verified date: January 2008
• Source: University of Wisconsin, Madison
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

Decline in muscle function may increase risk of hip fracture and decrease quality of life. Different tests are currently used to measure muscle function but they do not work for all individuals. A test called "jumping mechanography," which measures jumping power, may be useful in more people and obtain better information. This study will help us determine whether this test is able to detect differences between muscle function in younger and older adults, as well as whether it is a safe method to use in all ages.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 80
• Est. completion date: March 2008
• Est. primary completion date: March 2008
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 20 Years and older

Eligibility

Inclusion Criteria:

1. Women and men aged 20 to 30 or = 60 years

2. Able and willing to sign informed consent.

3. Ability to stand without assistance.

Exclusion Criteria:

1. Acute pain different and/or worse than the individuals chronic baseline pain

2. History of recent trauma to musculoskeletal system

3. Neuromuscular disease impairing balance to the degree of not being able to stand without assistance.

4. History of fragility fracture within the last year

5. Patients with a BMD T-score of less than -3.5 at any measured site and a vertebral fracture.

6. History of severe end-organ disease, e.g., cardiovascular, hepatic, hematologic, pulmonary, etc., which might limit the ability to complete this study.

7. Recent history of malignancy with metastasis to the musculoskeletal system.

Study Design

Observational Model: Cohort, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Muscle Weakness
• Musculoskeletal Status
• Paresis

Locations

Country	Name	City	State
United States	University of Wisconsin Osteoporosis Clinical and Research Program	Madison	Wisconsin

Sponsors (1)

Lead Sponsor	Collaborator
University of Wisconsin, Madison

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The primary outcome is the instantaneous weight corrected peak power taken from the maximal countermovement jump		single session	No